GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intelgenx Technologies Corp (FRA:0IL) » Definitions » EBITDA Margin %

Intelgenx Technologies (FRA:0IL) EBITDA Margin % : -1,743.75% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Intelgenx Technologies EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Intelgenx Technologies's EBITDA for the three months ended in Mar. 2024 was €-2.79 Mil. Intelgenx Technologies's Revenue for the three months ended in Mar. 2024 was €0.16 Mil. Therefore, Intelgenx Technologies's EBITDA margin for the quarter that ended in Mar. 2024 was -1,743.75%.


Intelgenx Technologies EBITDA Margin % Historical Data

The historical data trend for Intelgenx Technologies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelgenx Technologies EBITDA Margin % Chart

Intelgenx Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,176.95 -330.89 -458.76 -908.47 -725.18

Intelgenx Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,492.72 -1,743.09 -681.88 -148.08 -1,743.75

Competitive Comparison of Intelgenx Technologies's EBITDA Margin %

For the Biotechnology subindustry, Intelgenx Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intelgenx Technologies's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Intelgenx Technologies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Intelgenx Technologies's EBITDA Margin % falls into.



Intelgenx Technologies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Intelgenx Technologies's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-6.911/0.953
=-725.18 %

Intelgenx Technologies's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-2.79/0.16
=-1,743.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intelgenx Technologies  (FRA:0IL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Intelgenx Technologies EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Intelgenx Technologies's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Intelgenx Technologies Business Description

Traded in Other Exchanges
N/A
Address
6420 Abrams, Ville Saint Laurent, QC, CAN, H4S 1Y2
Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. The company focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer, and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and the United States. The company generates the majority of its revenue from Europe.

Intelgenx Technologies Headlines

No Headlines